NEW YORK (GenomeWeb News) – Rosetta Genomics has regained compliance with a Nasdaq rule that its stock meet a minimum $1 share price and will remain listed on the exchange, it announced after the close of the market on Thursday.
The company said that it has received notice from Nasdaq that it will continue being listed on the Nasdaq Capital Market under ticker symbol "ROSGD" through Aug. 3, then revert back to ticker symbol "ROSG" on Aug. 4.
Nasdaq rules stipulate that in order to be traded on its Capital Market, a company's stock must have a closing bid price of at least $1 for 10 consecutive trading days. Rosetta Genomics had been given until Aug. 8 to satisfy the condition.
Earlier this month, the Israeli microRNA-based molecular diagnostics company underwent a one-for-four reverse stock split to satisfy the requirement.
At the close of the market on Thursday, shares of Rosetta Genomics were down 6 percent at $1.50.